Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer

Part of paid clinical trials in Redondo Beach, California.

Sponsor
Helio Genomics
Study ID
NCT05181826
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Multi-analyte Blood Test — DIAGNOSTIC_TEST
    Intend for the qualitative detection of DNA methylation markers for the detection of various types of cancer

Study Details

To acquire blood samples from subjects for various purposes, including: i) determining the sensitivity and specificity of select DNA methylation markers for the detection of various types of cancer, ii) identifying benign conditions that may induce false positive or false negative results, and iii) defining the effects of potential interfering substances, such as chemotherapy drugs.

Key Dates

First listed
Jan 6, 2022
Start date
May 21, 2019
Status verified
Jul 2026
Primary completion
Dec 31, 2027
Completion
Jan 31, 2028

Study Design

Enrollment
1,200 participants (estimated)

Primary Outcome Measure

Independent performance measure of sensitivity and specificity of a multi-analyte blood test [ Time Frame: 1 month ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Torrance Memorial Physician Network - Cancer CareRedondo BeachCalifornia90277-
Allina Health, Virginia Piper Cancer InstituteCoon RapidsMinnesota55433
Kathryn Gruetzman
763-236-0814
Micheala Tsai, MD (PRINCIPAL_INVESTIGATOR)
Virginia Piper Cancer Institute Mercy Hospital-Unity CampusFridleyMinnesota55432
Lynne Schroeder
Micheala Tsai (PRINCIPAL_INVESTIGATOR)
VPCI Oncology ResearchMinneapolisMinnesota55407
Kelsey Froemming
Micheala Tsai, MD (PRINCIPAL_INVESTIGATOR)
Methodist LeBonheur HealthcareMemphisTennessee38104
Carol Jones
901-516-8078
Jiten Kothadia, MD (PRINCIPAL_INVESTIGATOR)
Liver Center of TexasDallasTexas75234
Ariela Moreno
Abdullah Mubarak, MD (PRINCIPAL_INVESTIGATOR)
Methodist HospitalRichardsonTexas75082
Araceli Torres
Rohan Jeyarajah, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Redondo Beach, CA

By condition

Related Studies